Nikon Corp. announced on August 3 the financial results for the first quarter ending on June 30, reporting that the total revenue for the period gained a 0.6% year-on-year to 170.3 billion yen, profit in operation declined 31.1% to 12.4 billion yen and net profit down 39.5% to 8.89 billion yen. In the Imaging Products segment, sales of mid-class cameras such as the D7500, a digital SLR camera released in June this year were firm, with unit sales increasing significantly in the U.S. Accordingly, the performance in revenue and operating profit exceeded the planned targets, but compared to the last year, a decease in revenue and operating profit was recorded due to a product mix change caused by the stagnant demand for the D5 and the D500. The company sold 720,000 units of interchangeable-lens cameras, 1.08 million units of interchangeable lenses and 770,000 compact digital cameras. The company said the unit sales of compact digital cameras declined but the average unit price rose about 30%.
Japan's leading printer and photocopier maker Konica Minolta Inc. announced at the company will be acquiring Ambry Genetic Corp. - a US diagnostic company, in a deal valued at up to USD 1 billion. This is one of the largest deals for Konica Minolta and the company will jointly carry out the acquisition with the funds provided by Innovation Network Corp of Japan. Konica Minolta, which has a market value of around $4 billion, will account for 60 percent of the investment and the Innovation Network Corp of Japan (INCJ) will provide for the remaining 40 percent. Both the companies intend to enter into the precision medicine segment which is expected to have a great potential for the treatment of cancer. KMI has its own diagnostic technique, utilising a High Sensitive Tissue Testing (HSTT) technology, while Ambry excels in genetic tests for breast, colon and cancers, heart and respiratory diseases, etc. Further, the company will combine its HSTT technology and Ambry's genetic diagnostic technology to offer high-standard cancer diagnostic services and aid the development of new reagents which will help produce new medicines. Talking about the acquisition, Shoei Yamana - Chief Executive Officer of Konica Minolta Inc., said, “Together with Ambry, we will have the most comprehensive set of diagnostic technologies for mapping an individual's genetic and biochemical makeup." The companies expect to complete the necessary procedure for the deal by the end of October, 2017 and post which, Ambry will become a subsidiary of KMI while Ambry's business will be continued in the US.
Canon India Pvt. Ltd., unveiled the highly anticipated EOS 6D Mark II, featuring a 26.2 megapixel full-frame CMOS sensor. Equipped with Dual Pixel CMOS AF and DIGIC 7 image processor, the EOS 6D Mark II possesses a continuous shooting speed of up to 6.5 fps. In Live View mode, it provides a continuous shooting speed up to 4 fps. The sensitivity ranges from ISO 100-40000 (expandable range 50- 102,400). It also provides a 5-axis image stabilization to support handheld shots. It features a 3.0-inch touchscreen vari-angle LCD monitor, the first in the Canon EOS series, and is equipped with a full-frame sensor. It supports 4K timelapse movie recording, Wi-Fi and NFC connectivity. The EOS 6D Mark II features Bluetooth low energy technology and is equipped with a GPS receiver. The EOS 6D Mark II will be available at the following prices: EOS 6D Mark II Body: INR 132,995 EOS 6D Mark II (w ith EF 2 4 70m m f/4L IS USM): INR 184,995 EOS 6D Mark II (w ith EF 24 105m m f/4L IS II USM): INR 202,995